IMM 0.00% 35.5¢ immutep limited

article: expanded use for prostate cancer drug

  1. 52 Posts.
    Apologies if this has already been posted, could not see a recent heading suggesting it -

    Dendreon's Provenge to be trialled for use earlier in the cancer treatment cycle. Good symmetry here, IMHO

    http://www.fiercepharma.com/story/dendreon-test-provenge-early-stage-cancer/2011-06-07?utm_medium=nl&utm_source=internal
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.000(0.00%)
Mkt cap ! $515.6M
Open High Low Value Volume
35.0¢ 36.0¢ 34.5¢ $670.1K 1.893M

Buyers (Bids)

No. Vol. Price($)
2 44785 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 22453 2
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.